Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (4899)	1/22/1998 1:26:00 AM
From: blankmind	Read Replies (2) \| Respond to of 23519

-- I didn't even consider a delay in Viagra. -- If Viagra isn't approved this quarter, or 2nd quarter at the latest, then Vivus's ability to crank out product and rack up revenues will be impressive. -- Some showed how production could actually increase by a factor of 5. I think on the first confer call - CEO Leland said the new plant could handle 8 or so lines - provided the demand was there. If so, you could be looking at close to $2 in the 4th qtr '98 - not just for the year. -- Can't forget that Vivus has done $125 mill in first year sales with no ad campaign. -- Also, over 2 mill shares traded today. Why? Perhaps some SOES activity. But I think a lot of new investors came in. Otherwise why the 2 point rise? -- So let's hope the shorts are toast. This weekend's Barron's should have the number of shorts in there. Out.